DiaMedica Therapeutics Inc. (DMAC) Return On Equity % [USD] 2018 - 2023

Historical data

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
DiaMedica Therapeutics Inc. quarterly/annual Return On Equity history and growth rate from 2018 to 2023.
  • DiaMedica Therapeutics Inc. Return On Equity for the quarter ending March 31, 2024 was -36.2 %, a 22.8% increase year-over-year.
  • DiaMedica Therapeutics Inc. annual Return On Equity for 2023 was -40.1 %, a 6.51% decline from 2022.
  • DiaMedica Therapeutics Inc. annual Return On Equity for 2022 was -37.6 %, a 6.9% increase from 2021.
  • DiaMedica Therapeutics Inc. annual Return On Equity for 2021 was -40.4 %, a 33.9% increase from 2020.
Return On Equity, Annual (% [USD])
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -40.1 -2.45 -6.51% Jan 1, 2023 Dec 31, 2023
2022 -37.6 +2.79 +6.9% Jan 1, 2022 Dec 31, 2022
2021 -40.4 +20.8 +33.9% Jan 1, 2021 Dec 31, 2021
2020 -61.2 +38.1 +38.3% Jan 1, 2020 Dec 31, 2020
2019 -99.2 -30.2 -43.8% Jan 1, 2019 Dec 31, 2019
2018 -69 Jan 1, 2018 Dec 31, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.